The effect of nitecapone, a new antioxidant, on myocardial function after aortic cross-clamping in experimental heart ischemia

International Journal of Angiology

Volumn 8, Issue 1, 1999, Pages 16-21

  Vento, Antti E ^a   Juhani Ramo O ^a   Pesonen, Eero J ^c   Heikkilä, Lasse ^a   Nissinen, Erkki ^b   Holopainen, Aila ^b   Mattila, Severi P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ORION CORPORATION   (Finland)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARDIOPLEGIC AGENT; NITECAPONE; PLEGISOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CRYSTALLOID; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0032954257     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01616836     Document Type: Article

References (22)

1. 1. Prasad K, Kalra J, Bharadwaj B, Chaudhary A (1992) Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 123:37-45.
2. 2. Zweier JL, Flaherty JT, Weisfeldt ML (1987) Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84:1404-1408.
3. 3. Menasche P, Piwnica A (1989) Free radicals and myocardial protection: A surgical viewpoint. Ann Thorac Surg 47:939-945.
4. 4. Ferrari R (1995) Metabolic disturbances during myocardial ischemia and reperfusion. Am J Cardiol 76:17B-24B.
5. 5. Reilly PM, Schiller HJ, Bulkley GB (1991) Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 161:488-503.
6. 6. Pentikäinen MO, Lindstedt KA, Kovanen PT (1995) Inhibition of the oxidative modification of LDL by nitecapone. Arterioscler Thromb Vasc Biol 15:740-747.
7. 7. Marcocci L, Suzuki YJ, Tsuchiya M, Packer L (1994) Antioxidant activity of nitecapone and its analog OR-1246: Effect of structure modification on antioxidant action. Methods Enzymol 234:528-541.
8. 8. Suzuki YJ, Tsuchiya M, Safadi A, Kagan VE, Packer L (1992) Antioxidant properties of nitecapone (OR-462). Free Radic Biol Med 13: 517-525.
9. 9. Valenza M, Serbinova E, Packer L (1993) Nitecapone protects the Langerdorff-perfused heart against ischemia-reperfusion injury. Biochem Mol Biol Int 29:443-149.
10. 10. Vasankari T, Kujala U, Heinonen O. Kapanen J, Ahotupa M (1995) Measurement of plasma lipid peroxidation during exercise using three different methods: Diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. Clin Chim Acta 234:63-69.
11. 11. Corongiu F, Lai M, Milai A (1983) Carbon tetrachloride, bromotrichlormethane and ethane acute intoxication. Biochem J 212:625-631.
12. 12. Bird P, Draper H (1984) Comparative studies on different methods of malonaldehyde determination. Methods Enzymol 105:299-305.
13. 13. Uotila J, Kirkkola A-L, Rorarius M, Tuimala R, Metsä-Ketelä T (1994) The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preclamptic parturients. Free Radic Biol Med 16:581-590.
14. 14. Rizzi A, Lang HRM (1985) Influence of the stationary phase on the retention characteristics of purine and pyrimidine bases, ribonucleoside and deoxyribonucleosides in reversed-phase high-performance liquid chromatography. J Chromatogr 331:33-45.
15. 15. Buckberg GD (1995) Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc Surg 110:1164-1170.
16. 16. Ihnken K, Morita K, Buckberg GD, Sherman MP, Young HH (1995) Studies of hypoxemic/reoxygenation injury without aortic clampìng. III. Comparison of the magnitude of damage by hypoxemia/ reoxygenation versus ischemia/reperfusion. J Thorac Cardiovasc Surg 110:1182-1189.
17. 17. Sundberg S, Scheinin M, Ojala-Karlsson P, Kaakkola S, Akkila J, Gordin A (1990) Exercise hemodynamics and catecholamine metabolism after cathechol-O-methyltranferase inhibition with nitecapone. Clin Pharmacol Ther 48:356-364.
18. 18. Haramaki N, Stewart DB, Aggarwal S, Kawabata T, Packer L (1995) Role of ascorbate in protection by nitecapone against cardiac ischemia-reperfusion injury. Biochem Pharmacol 50:839-843.
19. 19. Metsä-Ketälä T, Nissinen E, Korhonen T, Lindén I-B (1990) Radical-trapping antioxidative properties of nitecapone. Dig Dis Sci 35:1037.
20. 20. Nissinen E, Lindén I-B, Pohto P (1995) Antioxidant properties of nitecapone are potentiated by glutathione. Biochem Mol Biol Int 35: 387-395.
21. 21. Toivonen H, Ahotupa M (1994) Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting. J Thorac Cardiovasc Surg 108:140-147.
22. 22. Kooij A (1994) A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase. Histochem J 26:889-915.